文献速递肝病

瞬时弹性成像连续监测2型糖尿病患者的队列研究

Serial Transient Elastography Examinations to Monitor Patients With Type 2 Diabetes: A Prospective Cohort Study.
PubMed 文献 · Hepatology · 2020-10-13

该前瞻性队列研究纳入611例2型糖尿病患者,在2013-2014年及2016-2018年重复评估瞬时弹性成像。基线LSM<10 kPa者中仅4.3%随访升至≥10 kPa,而基线LSM≥10 kPa者中56.5%随访降至<10 kPa。结论认为该人群NAFLD患病率与发病率高,但3年内进展至进展期纤维化者少。

要点

  • 2型糖尿病患者3年内进展至LSM≥10 kPa的比例较低(4.3%)。
  • 基线LSM≥10 kPa者中过半在随访时LSM降至<10 kPa。
  • 基线BMI、ALT及ALT变化与LSM升高独立相关。

核心结论

  • 2型糖尿病患者中NAFLD患病率和发病率均高,但3年内进展至进展期纤维化者少。

研究设计与样本

  • 前瞻性队列研究,2013-2014年从香港并发症筛查机构招募无病毒性肝炎或过量饮酒的2型糖尿病患者,2016-2018年重复评估。
  • 共611例有有效LSM的患者纳入分析(平均年龄57.7±10.9岁;342例男性[56.0%]),其中568例有有效CAP。

主要发现

  • 基线与随访LSM呈中度相关(r=0.689,P<0.001)。
  • 基线LSM<10 kPa的487例中,21例(4.3%)随访LSM≥10 kPa。
  • 基线LSM≥10 kPa的124例中,70例(56.5%)随访LSM<10 kPa。
  • 基线CAP<248 dB/m的198例中,103例(52.0%)随访CAP升至≥248 dB/m。
  • 基线BMI、ALT及∆ALT是与LSM升高独立相关的因素。

关键数值与推荐

  • 主要终点为LSM升高至≥10 kPa。
  • 次要终点为CAP的变化。

临床怎么用

  • 对于2型糖尿病患者,瞬时弹性成像可用于NAFLD的初始评估与随访监测。
  • 基线LSM<10 kPa者3年内进展风险低,但需关注BMI、ALT等指标。
  • 基线LSM≥10 kPa者部分可回落,监测中应结合其他指标综合判断。

局限性

  • 研究未明确最佳监测间隔,未来需进一步研究。
  • 样本来自香港单中心并发症筛查机构,外推性需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Type 2 diabetes is an important risk factor for nonalcoholic fatty liver disease (NAFLD) and advanced fibrosis. Current international guidelines recommend the use of noninvasive tests as initial assessments for NAFLD, but the role of noninvasive tests as monitoring tools has not been established. We aimed to study the role of transient elastography as a monitoring tool in patients with type 2 diabetes. APPROACH AND RESULTS: We recruited patients with type 2 diabetes without viral hepatitis or excessive alcohol intake from a complication screening facility in Hong Kong in 2013-2014 and repeated the assessments in 2016-2018. The primary endpoint was an increase of liver stiffness measurement (LSM) to ≥10 kPa. The secondary endpoint was the change in the controlled attenuation parameter (CAP). A total of 611 patients with type 2 diabetes and a valid LSM (mean age, 57.7 ± 10.9 years; 342 men [56.0%]) were included in this study (568 also had a valid CAP). Overall, there was moderate correlation between the baseline and follow-up LSM (r = 0.689, P < 0.001). Among 487 patients with a baseline LSM <10 kPa, 21 (4.3%) had a follow-up LSM ≥10 kPa. Baseline body mass index, alanine aminotransferase (ALT), and ∆ALT were independent factors associated with LSM increase. Among 124 patients with a baseline LSM ≥10 kPa, 70 (56.5%) had a follow-up LSM <10 kPa. Among 198 patients with a CAP <248 dB/m at baseline, 103 (52.0%) had a CAP increased to ≥248 dB/m. CONCLUSIONS: The prevalence and incidence of NAFLD in patients with type 2 diabetes are high. Although advanced fibrosis is common in this population, few patients progress to advanced fibrosis in 3 years. Future studies should define the optimal surveillance interval in patients with diabetes.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Lee HW, Wong GL, Kwok R, et al. Serial Transient Elastography Examinations to Monitor Patients With Type 2 Diabetes: A Prospective Cohort Study. Hepatology. 2020. PMID: 31991487. doi:10.1002/hep.31142

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。